These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 8064785)

  • 1. Apparent mineralocorticoid excess.
    Benediktsson R; Edwards CR
    J Hum Hypertens; 1994 May; 8(5):371-5. PubMed ID: 8064785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human hypertension caused by mutations in the 11 beta-hydroxysteroid dehydrogenase gene: a molecular analysis of apparent mineralocorticoid excess.
    Whorwood CB; Stewart PM
    J Hypertens Suppl; 1996 Dec; 14(5):S19-24. PubMed ID: 9120678
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Furosemide and 11beta-hydroxysteroid dehydrogenase activity, in man.
    Palermo M; Armanini D; Shackleton CH; Sorba G; Cossu M; Roitman E; Scaroni C; Delitala G
    Exp Clin Endocrinol Diabetes; 2002 Sep; 110(6):272-6. PubMed ID: 12373630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A case of apparent mineralocorticoid excess caused by type 2 11 beta- hydroxysteroid dehydrogenase deficiency].
    Morineau G; Pascoe L; Marc JM; Caillette A; Krozowski Z; Corvol P; Fiet J
    Arch Mal Coeur Vaiss; 1997 Aug; 90(8):1111-5. PubMed ID: 9404418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apparent mineralocorticoid excess syndromes.
    Shimojo M; Stewart PM
    J Endocrinol Invest; 1995; 18(7):518-32. PubMed ID: 9221270
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessing systemic 11beta-hydroxysteroid dehydrogenase with serum cortisone/cortisol ratios in healthy subjects and patients with diabetes mellitus and chronic renal failure.
    Homma M; Tanaka A; Hino K; Takamura H; Hirano T; Oka K; Kanazawa M; Miwa T; Notoya Y; Niitsuma T; Hayashi T
    Metabolism; 2001 Jul; 50(7):801-4. PubMed ID: 11436185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Congenital and acquired syndromes of apparent mineralocorticoid excess.
    Edwards CR; Walker BR; Benediktsson R; Seckl JR
    J Steroid Biochem Mol Biol; 1993 Apr; 45(1-3):1-5. PubMed ID: 8386930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apparent mineralocorticoid excess.
    Funder JW
    Endocrinol Metab Clin North Am; 1995 Sep; 24(3):613-21. PubMed ID: 8575412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Syndrome of apparent mineralocorticoid excess. A defect in the cortisol-cortisone shuttle.
    Stewart PM; Corrie JE; Shackleton CH; Edwards CR
    J Clin Invest; 1988 Jul; 82(1):340-9. PubMed ID: 3164727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [From gene to disease; 'apparent mineralocorticoid excess' syndrome, a syndrome with an apparent excess of mineral corticoids].
    Levtchenko EN; Deinum J; Knoers NV; Hermus AR; Monnens LA; Lenders JW
    Ned Tijdschr Geneeskd; 2007 Mar; 151(12):692-4. PubMed ID: 17447595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apparent mineralocorticoid excess syndrome: report of one family with three affected children.
    Al-Harbi T; Al-Shaikh A
    J Pediatr Endocrinol Metab; 2012; 25(11-12):1083-8. PubMed ID: 23329753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apparent mineralocorticoid excess type II.
    Mantero F; Tedde R; Opocher G; Dessi Fulgheri P; Arnaldi G; Ulick S
    Steroids; 1994 Feb; 59(2):80-3. PubMed ID: 8191552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Administration of glycyrrhetinic acid: significant correlation between serum levels and the cortisol/cortisone-ratio in serum and urine.
    Heilmann P; Heide J; Hundertmark S; Schöneshöfer M
    Exp Clin Endocrinol Diabetes; 1999; 107(6):370-8. PubMed ID: 10543414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 11 beta-Hydroxysteroid dehydrogenases: tissue-specific dictators of glucocorticoid action.
    Benediktsson R; Edwards CR
    Essays Biochem; 1996; 31():23-36. PubMed ID: 9078455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hypokalemia without arterial hypertension by licorice poisoning].
    Luchon L; Meyrier A; Paillard F
    Nephrologie; 1993; 14(4):177-81. PubMed ID: 8232712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cortisol, 11beta-hydroxysteroid dehydrogenases, and hypertension.
    van Uum SH; Lenders JW; Hermus AR
    Semin Vasc Med; 2004 May; 4(2):121-8. PubMed ID: 15478032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A mutation in the cofactor-binding domain of 11beta-hydroxysteroid dehydrogenase type 2 associated with mineralocorticoid hypertension.
    Odermatt A; Dick B; Arnold P; Zaehner T; Plueschke V; Deregibus MN; Repetto H; Frey BM; Frey FJ; Ferrari P
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1247-52. PubMed ID: 11238516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mineralocorticoid activity of liquorice: 11-beta-hydroxysteroid dehydrogenase deficiency comes of age.
    Stewart PM; Wallace AM; Valentino R; Burt D; Shackleton CH; Edwards CR
    Lancet; 1987 Oct; 2(8563):821-4. PubMed ID: 2889032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 11 beta-Hydroxysteroid dehydrogenase and the syndrome of apparent mineralocorticoid excess.
    White PC; Mune T; Agarwal AK
    Endocr Rev; 1997 Feb; 18(1):135-56. PubMed ID: 9034789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [11 beta-Hydroxysteroid dehydrogenase].
    Sun G; Li P; Yang KP; Challis JR
    Sheng Li Ke Xue Jin Zhan; 1998 Oct; 29(4):301-6. PubMed ID: 12501657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.